Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity.

Authors: Wilk, Anna; Hayat, Faisal; Cunningham, Richard; Li, Jianfeng; Garavaglia, Silvia; Zamani, Leila; Ferraris, Davide M; Sykora, Peter; Andrews, Joel; Clark, Jennifer; Davis, Amanda; Chaloin, Laurent; Rizzi, Menico; Migaud, Marie; Sobol, Robert W

Published In Sci Rep, (2020 01 20)

Abstract: Changes in nicotinamide adenine dinucleotide (NAD+) levels that compromise mitochondrial function trigger release of DNA damaging reactive oxygen species. NAD+ levels also affect DNA repair capacity as NAD+ is a substrate for PARP-enzymes (mono/poly-ADP-ribosylation) and sirtuins (deacetylation). The ecto-5'-nucleotidase CD73, an ectoenzyme highly expressed in cancer, is suggested to regulate intracellular NAD+ levels by processing NAD+ and its bio-precursor, nicotinamide mononucleotide (NMN), from tumor microenvironments, thereby enhancing tumor DNA repair capacity and chemotherapy resistance. We therefore investigated whether expression of CD73 impacts intracellular NAD+ content and NAD+-dependent DNA repair capacity. Reduced intracellular NAD+ levels suppressed recruitment of the DNA repair protein XRCC1 to sites of genomic DNA damage and impacted the amount of accumulated DNA damage. Further, decreased NAD+ reduced the capacity to repair DNA damage induced by DNA alkylating agents. Overall, reversal of these outcomes through NAD+ or NMN supplementation was independent of CD73. In opposition to its proposed role in extracellular NAD+ bioprocessing, we found that recombinant human CD73 only poorly processes NMN but not NAD+. A positive correlation between CD73 expression and intracellular NAD+ content could not be made as CD73 knockout human cells were efficient in generating intracellular NAD+ when supplemented with NAD+ or NMN.

PubMed ID: 31959836 Exiting the NIEHS site

MeSH Terms: 5'-Nucleotidase/genetics; 5'-Nucleotidase/metabolism*; 5'-Nucleotidase/physiology*; DNA Damage*; DNA Repair*; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mitochondria/physiology; NAD/metabolism*; NAD/physiology*; Poly ADP Ribosylation*; Poly(ADP-ribose) Polymerases/physiology*; Reactive Oxygen Species/metabolism; Sirtuins; Tumor Microenvironment/genetics*; Tumor Microenvironment/physiology*; X-ray Repair Cross Complementing Protein 1/metabolism

to Top